Medical Billing · Nationwide
Neurology Medical Billing Services
Electrodiagnostic testing, complex chronic neurological care, and infusion therapies where technical/professional split billing and prior authorization rules dominate cash flow.
Aethera Healthcare Solutions provides full-service medical billing and revenue cycle management to neurology and neurophysiology practices across the United States. We handle coding, claims, payment posting, denial management, and A/R follow-up end to end — so your team can stay focused on patient care while your revenue cycle runs cleanly.
Typical neurology CPT range we work: 95810–95822, 95886–95913, 99202–99215, 64615.
Why neurology billing leaks revenue
EMG and nerve conduction study (NCS) units are capped and frequently audited by Medicare MACs without strict medical necessity documentation
Botox chemodenervation (CPT 64615) for chronic migraine triggers high-dollar claim denials when drug wastage (JW/JZ modifiers) is misreported
EEG and ambulatory sleep study interpretation versus technical component split (26/TC) requires rigorous billing separation
Infusion billing for MS and neuropathy biologics requires flawless J-code NDC pairing and prior authorization
How Aethera fixes it
Specialty-trained coders (CPC/CCS) code to the documentation
First-pass claim scrubbing against payer and NCCI edits
Proactive denial prevention and 72-hour denial work
Relentless A/R follow-up to drive days-in-A/R down
Eligibility and prior-auth verification before service
Transparent, real-time reporting in the provider portal
Free tools for your billing team
Use these any time — no login required.
Neurology billing FAQ
How do you prevent denials on electrodiagnostic testing (EMG/NCS)?
We verify documented clinical indications against local Medicare MAC LCDs (Local Coverage Determinations) and ensure specific motor/sensory nerve counts match the billed CPT codes before submission.
How do you handle Botox wastage and J-code reporting?
We apply the required JW or JZ modifier with exact units administered and units discarded according to CMS regulations, preventing drug clawback audits.